Catalyst Wire Dossier Catalyst Wire Dossier

Elzonris

tagraxofusp · Stemline Therapeutics
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Elzonris, covering 2018-12-21 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy [Phase 2]

See pricing